Intchains Group: Ethereum Holdings Rise to 8,816 in Q2, Up 25.5% Quarter-on-Quarter
According to a report by Jinse Finance, Nasdaq-listed Intchains Group has released its unaudited financial results for the second quarter and first half of 2025. The report reveals that the company has officially launched its Ethereum strategic reserve, having increased its holdings by 1,321 ETH in the first quarter and 1,793 ETH in the second quarter of this year. As of the end of the second quarter, the total Ethereum holdings reached 8,816 ETH, representing a quarter-on-quarter increase of 25.5%. Excluding stablecoins such as USDT and USDC, the fair value of the company's cryptocurrency assets reached 157.7 million RMB.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ido Ben-Natan: Frequent on-chain security incidents, AI agents will increase risks

BTC rebounds and breaks through 83,000 USDT, with a 24-hour decrease of 1%

Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly
The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
